These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3181291)

  • 41. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
    Frankfurt M; Allen DL; Luine VN; Beaudet A
    Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5,7-Dihydroxytryptamine modifies excitability of rat dorsal raphe serotonergic neurons in vitro.
    Segal M
    Neurosci Lett; 1986 Nov; 71(3):306-10. PubMed ID: 3796886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia.
    Chance WT; von Meyenfeldt M; Fischer JE
    Pharmacol Biochem Behav; 1983 Jan; 18(1):115-21. PubMed ID: 6187026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrahypothalamic 5,7-dihydroxytryptamine facilitates feminine sexual behavior and decreases [3H]imipramine binding and 5-HT uptake.
    Luine VN; Frankfurt M; Rainbow TC; Biegon A; Azmitia E
    Brain Res; 1983 Apr; 264(2):344-8. PubMed ID: 6850308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
    Kirby ML; Mattio TG
    Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1980 Feb; 67(2):143-6. PubMed ID: 6768090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
    Brown LM; Smith DL; Williams GM; Smith DJ
    Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anxiety-like behavior in rats neonatally and adultly treated with 5,7-dihydroxytryptamine].
    Yamada I; Iwasaki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):145-51. PubMed ID: 12451684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord.
    Sharif NA; Towle AC; Burt DR; Mueller RA; Breese GR
    Brain Res; 1989 Feb; 480(1-2):365-71. PubMed ID: 2540880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
    Warbritton JD; Stewart RM; Baldessarini RJ
    Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of depletion of brain 5-hydroxytryptamine by 5,7-dihydroxytryptamine on ethanol tolerance and dependence in the rat.
    Wood JM
    Psychopharmacology (Berl); 1980 Jan; 67(1):67-72. PubMed ID: 6768080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Randomized Clinical Trial Comparing the Effects of Antitussive Agents on Respiratory Center Output in Patients With Chronic Cough.
    Mannini C; Lavorini F; Zanasi A; Saibene F; Lanata L; Fontana G
    Chest; 2017 Jun; 151(6):1288-1294. PubMed ID: 28192113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of epinastine on the antitussive and rewarding effects of dihydrocodeine in mice.
    Kamei J; Morita K; Ohsawa M; Onodera K
    Methods Find Exp Clin Pharmacol; 1999 Dec; 21(10):663-8. PubMed ID: 10702962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Model of central chemical 'serotoninectomy' in mice.
    Herman ZS; Bonczek A
    Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
    J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of 5,7-dihydroxytryptamine-induced supersensitivity to 5-hydroxytryptophan in mice by treatment with cycloheximide.
    Sperk G; Stewart RM; Campbell A; Baldessarini RJ
    Brain Res; 1978 Dec; 159(1):183-94. PubMed ID: 310331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5,7-DHT-induced muricide: inhibition as a result of preoperative exposure of rats to mice.
    Marks PC; O'Brien M; Paxinos G
    Brain Res; 1977 Oct; 135(2):383-8. PubMed ID: 562701
    [No Abstract]   [Full Text] [Related]  

  • 59. Injection of 5,7-dihydroxytryptamine into the B3 raphe region of neonatal rat pups induces hyperalgesia but only slight alterations in ingestion-related behaviors.
    Enters EK; Specht SM; Spear LP
    Behav Neural Biol; 1990 Mar; 53(2):244-57. PubMed ID: 1691912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors.
    Heal DJ; Philpot J; Molyneux SG; Metz A
    Neuropharmacology; 1985 Dec; 24(12):1201-5. PubMed ID: 4094656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.